Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Alimatravir

09.09.2026

Aspen has abandoned local lenacapavir production, citing no guaranteed demand, and is backing Merck's alimatravir pill instead.

27.07.2026

Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.

Search the archive

Browse by month